In the last week, the Indian market has stayed flat, yet it is up 44% over the past year with earnings expected to grow by 17% per annum in the next few years. In this dynamic environment, identifying ...

Over the last 7 days, the Indian market has remained flat, with notable gains of 3.5% in the Utilities sector. Despite this ...

In the last week, the Indian market has stayed flat, but it is up 44% over the past year with earnings forecast to grow by 17 ...

UBS sold holdings in Concord Biotech, Five Star Business Finance, IIFL Securities, and Marksans Pharma through block deals, ...

US-based financial services company Vanguard Group acquired shares worth Rs 998 crore in seven Indian companies via open market transactions on the NSE. Concurrently, Zurich-based UBS Group AG sold ...

US-based financial services company Vanguard Group on Friday bought shares of seven companies including Concord Biotech, Five ...

Vanguard Group, a US-based financial services company, has purchased shares in seven Indian companies, including Concord ...

Sumeet Bagadia recommends five shares to buy today — Marksans Pharma, Concord Biotech, Magadh Sugar, Prism Johnson, and ...

Marksans Pharma, Concord Biotech Ltd., Interarch Building and Themis Medicare, hit their fresh 52-week highs during the day.

UBS Principal Capital Asia Ltd. sold stakes in Concord Biotech Ltd., Five-Star Bus Fin Ltd., IIFL Securities Ltd. and ...

On September 20, Vanguard Group bought shares worth around Rs 1000 crore in seven Indian listed companies via a bulk deal.